Therapeutic approaches to bladder cancer: identifying targets and mechanisms
- 17 May 2003
- journal article
- review article
- Published by Elsevier in Critical Reviews in Oncology/Hematology
- Vol. 46, 67-83
- https://doi.org/10.1016/s1040-8428(03)00066-0
Abstract
No abstract availableKeywords
This publication has 95 references indexed in Scilit:
- Neo-adjuvant chemotherapy in invasive bladder cancer.World Journal of Urology, 2001
- Immunotherapy for bladder cancerCurrent Urology Reports, 2001
- CURRENT USE AND QUESTIONS CONCERNING INTRAVESICAL BLADDER CANCER GROUP FOR SUPERFICIAL BLADDER CANCERUrologic Clinics of North America, 2000
- A Randomized Multicenter Trial of Adjuvant Therapy in Superficial Bladder Cancer: Transurethral Resection Only Versus Transurethral Resection Plus Mitomycin C Versus Transurethral Resection Plus Bacillus Calmette-GuerinJournal of Urology, 1996
- A Randomized Prospective Study Comparing Long-Term Intravesical Instillations of Mitomycin C and Bacillus Calmette-Guerin in Patients with Superficial Bladder CarcinomaJournal of Urology, 1996
- Original Articles: Bladder Cancer: A Randomized Study of Intravesical Mitomycin C, Bacillus Calmette-Guerin Tice and Bacillus Calmette-Guerin RIVM Treatment in pTa-pT1 Papillary Carcinoma and Carcinoma in Situ of the BladderJournal of Urology, 1995
- A Randomized Trial of Intravesical Doxorubicin and Immunotherapy with Bacille Calmette–Guérin for Transitional-Cell Carcinoma of the BladderNew England Journal of Medicine, 1991
- Intravesical Chemotherapy (Mitomycin C) versus Immunotherapy (Bacillus Calmette-Guérin) in Superficial Bladder CancerEuropean Urology, 1991
- 16 Years Experience in the Management of Patients with Deeply Invasive Bladder CancerEuropean Urology, 1988
- Management of Invasive Bladder Cancer: A Meticulous Pelvic Node Dissection Can Make a DifferenceJournal of Urology, 1982